Pincus Capital Management LP purchased a new stake in shares of Danaher Corporation (NYSE:DHR – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 3,677 shares of the conglomerate’s stock, valued at approximately $842,000.
A number of other institutional investors and hedge funds have also modified their holdings of DHR. Norges Bank purchased a new position in shares of Danaher during the fourth quarter valued at $2,177,106,000. Viking Global Investors LP grew its holdings in shares of Danaher by 543.9% during the second quarter. Viking Global Investors LP now owns 2,907,515 shares of the conglomerate’s stock valued at $574,351,000 after buying an additional 2,455,994 shares in the last quarter. Massachusetts Financial Services Co. MA grew its stake in Danaher by 104.7% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 4,333,056 shares of the conglomerate’s stock valued at $991,923,000 after purchasing an additional 2,216,789 shares in the last quarter. Generation Investment Management LLP grew its stake in Danaher by 34.0% in the third quarter. Generation Investment Management LLP now owns 6,654,666 shares of the conglomerate’s stock valued at $1,319,354,000 after purchasing an additional 1,689,020 shares in the last quarter. Finally, Ameriprise Financial Inc. grew its stake in Danaher by 211.7% in the third quarter. Ameriprise Financial Inc. now owns 2,088,089 shares of the conglomerate’s stock valued at $414,038,000 after purchasing an additional 1,418,243 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.
Danaher Price Performance
NYSE DHR opened at $180.07 on Tuesday. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. The stock has a market capitalization of $127.45 billion, a PE ratio of 34.83, a P/E/G ratio of 2.44 and a beta of 0.81. The stock has a 50-day simple moving average of $181.91 and a 200 day simple moving average of $207.20.
Danaher Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s payout ratio is currently 30.95%.
Analyst Ratings Changes
A number of research analysts have commented on the company. Rothschild & Co Redburn set a $205.00 target price on Danaher in a research note on Friday, April 17th. Jefferies Financial Group restated a “buy” rating and issued a $245.00 target price on shares of Danaher in a research note on Tuesday, April 21st. Wall Street Zen downgraded Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, April 25th. JPMorgan Chase & Co. lowered their target price on Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. Finally, Morgan Stanley lowered their target price on Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. Nineteen research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $238.24.
Check Out Our Latest Analysis on DHR
About Danaher
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Stories
- Five stocks we like better than Danaher
- Why 1 Little-Known ETF Is Riding the AI Chip Shortage
- Why These Three Big Buybacks Are Sending Very Different Signals to Investors
- Drone Stocks Soar As Pentagon Considers Funding, Including a Trump-Linked Name
- Braze Blazes Ahead on Q1 2027 Earnings Beat, Raised Guidance
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
